Sonneborn Announces New CFO
Sonneborn announces that it named Gregg Kam as its new chief financial officer.
Sonneborn has appointed Gregg Kam as chief financial officer (CFO), reporting directly to CEO and president, Paul Raymond III, PhD. Kam previously served as CFO of International Specialty Products and The Newark Group. He also held positions at National Starch & Chemical Company as CFO for the US Adhesives business, CFO for the Latin American division, CFO for a graphite lubricant and electronic materials business (Acheson Industries), and CFO of the Specialty Polymers Group.
“Gregg’s track record of financial leadership and business success in the global chemical industry is a great fit for Sonneborn. I’m excited to add Gregg to an already strong team focused on growing our business and continuing to improve our results,” said Paul Raymond III, Sonneborn CEO and president, in a press release.
Source: Sonneborn
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
